Coral Laboratories share news, announcements and annual reports
BSE: 524506Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 2 Nov 2026. Previous close ₹484.35.
2 Nov: open ₹498.00, high ₹500.00, low ₹480.15
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹179 Cr2,551st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 9.29
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.85
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.40%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 9.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.02
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 875
Coral Laboratories share news and announcements
720 announcements, routine notices left out, newest first. Page 8 of 15.
Nov 2019
4 Nov · Board meeting
Meeting on 12 Nov 2019: quarterly results
Oct 2019
23 Oct · Shareholding for the Period Ended September 30, 2019
Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click ....11 Oct · Compliance Certificate From PCS As Per Regulation 40(9)And 40(10) Under SEBI (Listing Obligations And Disclosure Requirements), Regulations 2015
11 Oct · Compliance Certificate From RTA As Per Regulation 7(3) Under SEBI (Listing Obligations And Disclosure Requirements), Regulations 2015
9 Oct · Statement Of Investor Complaints For The Quarter Ended September 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 07 Oct · Regulation 32(1) Under SEBI (Listing Obligations And Disclosure Requirements), Regulations 2015
Sep 2019
30 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....28 Sep · VOTING RESULT UNDER REGULATION 44 UNDER SEBI(LISTING OBLIGATION AND DISCLOSURE REQUIREMENT,REGULATION 2015
5 Sep · Reg. 34 (1) Annual Report
Aug 2019
13 Aug · Corporate action
5 Aug · Board meeting
Meeting on 12 Aug 2019: annual general meeting and quarterly results
Jul 2019
20 Jul · Shareholding for the Period Ended June 30, 2019
Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click ....8 Jul · Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 2 0 2 04 Jul · Regulation 32(1) Under SEBI (Listing Obligations And Disclosure Requirements), Regulations 2015
Jun 2019
18 Jun · Disclosure Under Reg. 23(9) Of SEBI (LODR) Regulations, 2015
May 2019
28 May · Management
28 May · Results
20 May · Board meeting
Meeting on 28 May 2019: audited results and dividend
Apr 2019
22 Apr · Compliances-Certificate under Reg. 54 (5) of SEBI (DP) Regulations, 1996
19 Apr · Shareholding for the Period Ended March 31, 2019
Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click ....18 Apr · Compliance Certificate From RTA As Per Regulation 7(3) Under SEBI (Listing Obligations And Disclosure Requirements), Regulations 2015
15 Apr · Management
10 Apr · CERTIFICATE UNDER REGULATION 40(9) UNDER SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS), REGULATIONS 2015 FOR HALF YEAR ENDED 31St MARCH, 2019
9 Apr · Regulation 32(1) Under SEBI (Listing Obligations And Disclosure Requirements), Regulations 2015
9 Apr · Statement Of Investor Complaints For The Quarter Ended March 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 3 1 2